04.11.2019
- US biotech Amgen has agreed to take a 20.5% stake in China’s BeiGene as the two companies enter into a strategic collaboration to develop cancer drugs. The move significantly...
17.04.2018
- For the global specialty chemicals sector, the past two years have been among the most exciting of the young millennium. Many mergers and acquisitions were in the spotlight in 2017...
13.07.2017
- US biopharmaceutical company Celgene has agreed to buy a stake in China’s BeiGene and help to develop and commercialize that company’s investigational treatment for tumor cancers...
